Launch and Award for Benvenue’s Luna® 3D Interbody Fusion System

Keen to stand out from the pack of news releases that accompanies this year’s NASS spinal jamboree, Benvenue Medical, Inc., is announcing the U.S. commercial launch of its Luna® 3D Interbody Fusion System, while also accepting the 2015 Spine Technology Award for the device in the Minimally Invasive Spine and Thoracolumbar Care categories.


Luna 3D is a new expandable interbody designed for minimally invasive surgery (MIS), mini-open or open posterior approaches. Luna 3D’s controlled, atraumatic insertion through a 6-8 mm cannula is designed to minimize nerve retraction and mitigate implant migration. In-situ 3D expansion provides zero-impaction delivery, intended to preserve and protect vertebral endplates. Once in the disc space, Luna 3D expands to 25 mm in diameter and up to 13 mm in height. Bone graft is inserted into the Luna 3D cage after expansion, thereby optimizing this critical aspect of fusion surgery.

Luna 3D’s full-scale launch follows a successful limited rollout, in which more than 100 patient levels were treated via both minimally invasive and open TLIF approaches. Luna 3D was cleared by the FDA in November 2014 and represents the next generation of expandable interbody fusion devices.

Physician comments

“Luna 3D is a significant improvement over other available static and expandable TLIF cages,” said Michael Wang, MD, chief of neurosurgery at University of Miami Health System. “Due to the implant’s cannula delivery, implantation is possible through a narrow surgical corridor, resulting in minimal nerve root retraction and tissue dissection.”

Company comments

“The launch of Luna 3D and its recognition as a spine technology of the year further solidifies Benvenue Medical as an innovative company focused on minimally invasive spine,” said Robert K. Weigle, CEO of Benvenue Medical, Inc. “Our portfolio features award-winning, proprietary expandable technology that is well-positioned for spine surgeons’ clinical requirements while serving the unmet needs of the open and MIS spinal implant markets.”

Source: Benvenue Medical, Inc.

Share your thoughts

Your email address will not be published. Required fields are marked *